Investigational Site Number : 3760002

Afula 1834111

1 studies enrolling now · 2 studies all time

What they study most

Celiac Disease, Coeliac Disease, Sickle Cell Disease

Studies at this site

• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease — Recruiting now
• A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease — Running, not enrolling